Zentalis Pharmaceuticals (ZNTL) Other Non Operating Income (2021)

Zentalis Pharmaceuticals' Other Non Operating Income history runs 1 years deep, the most recent figure standing at $51.6 million for Q3 2021.

• In Q3 2021, Other Non Operating Income changed N/A year-over-year to $51.6 million; the TTM figure through Dec 2022 stood at $51.6 million (changed 0.0% YoY), while the FY2021 annual figure was $51.6 million, changed N/A from the prior year.
• Other Non Operating Income for Q3 2021 stood at $51.6 million.
• The five-year high for Other Non Operating Income was $51.6 million in Q3 2021, with the low at $51.6 million in Q3 2021.